Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virus

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 1, 1998, Pages 91-97

  Jenson, Hal B ^a,b   Grant, George M ^a   Ench, Yasmin ^a   Heard, Patty ^a   Thomas, Charles A ^a   Hilsenbeck, Susan G ^a   Moyer, Mary Pat ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL VIABILITY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 0031905879     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.1.91-97.1998     Document Type: Article

References (50)

1. Anisimová, E., K. Prachová, J. Roubal, and V. Vonka. 1984. Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation. Arch. Virol. 81:223-237.
2. Anisimová, E., A. K. Saemundsen, J. Roubal, V. Vonka, and G. Klein, 1982. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines. J. Gen. Virol. 58:163-171.
3. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Séguin, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
4. Benz, W. C., P. J. Siegel, and J. Baer. 1978. Effects of adcnine arabinoside on lymphocytes infected with Epstein-Barr virus. J. Virol. 27:475-482.
5. Bister. K., N. Yamamoto, and H. zur Hausen, 1979. Differential inducihility of Epstein-Barr virus in cloned, non-producer Raji cells. Int. J. Cancer 23:818-825.
6. Blacklow, N. R., B. K. Watson, G. Miller, and B. M. Jacobson, 1971. Mononucleosis with heterophil antibodies and EB virus infection. Acquisition by an elderly patient in hospital. Am. J. Mcd. 51:549-552.
7. Boos, H., R. Berger, C. Kuklik-Roos, T. lftner, and N. Mueller-Lantzsch. 1987. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells. Virology 159:161-165.
8. Bouvier, G., S. Poirier, Y. M. Shao, C. Malaveille, H. Ohshima, A. Polack, G. W. Bornkamm, Y. Zeng, G. de-Thé, and H. Bartsch. 1991. Epstein-Barr virus activators, mutagens and volatile nitrosamines in preserved food samples from high-risk areas for nasopharyngeal carcinoma. IARC Sci. Publ. 105:204-209.
9. Cook, I. D., F. Shanahan, and P. J. Farrell. 1994. Epstein-Barr virus SM protein. Virology 205:217-227.
10. Countryman, J., H. Jenson, R. Seibl, H. Wolf, and G. Miller. 1987. Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J. Virol. 61:3672-3679.
11. Decaussin, G., V. Leclerc, and T. Ooka. 1995. The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame. J. Virol. 69:7309-7314.
12. Epstein, M. A., B. G. Achong, Y. M. Barr, B. Zajac, G. Henle, and W. Henle. 1966. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J. Natl. Cancer Inst. 37:547-559.
13. Flemington, E., and S. H. Speck. 1990. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZEF1. J. Virol. 64:1217-1226.
14. Gerber, P. 1972. Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells. Proc. Natl. Acad. Sci. USA 69:83-85.
15. Hammerschmidt, W., and B. Sugden. 1988. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55:427-433.
16. Hampar, B., J. G. Derge, L. M. Martos, and J. L. Walker. 1971. Persistence at a repressed Epslein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine. Proc. Natl. Acad. Sci. USA 68:3185-3189.
17. Hatfull, G., A. T. Bankier, B. G. Barrell, and P. J. Farrell. 1988. Sequence analysis of Raji Epstein-Barr virus DNA. Virology 164:334-340.
18. Hayashi, K. 1992. Effect of protein kinase C inhibitors with different action mechanisms on Epstein-Barr virus replication. Intervirology 33:217-224.
19. Henle, W., G. Henle, B. A. Zajae, G. Pearson, R. Waubke, and M. Scriba. 1970. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science 169:188-190.
20. Jenson, H. B., Y. Ench, and C. V. Sumaya. 1997. Epstein-Barr virus, p. 634-643. In N. R. Rose, E. C. de Macario, H. Folds, H. C. Lane, and R. M. Nakamura (ed.), Manual of clinical laboratory immunology, 5th ed. Amercan Society for Microbiology, Washington, D.C.
21. Kallin, B., J. Luka, and G. Klein. 1979. lmmunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells. J. Virol. 32:710-716.
22. Kiehl, A., and D. I. Dorsky. 1995. Bipartite DNA-binding region of the Epstein-Barr virus BMRF1 product essential for DNA polymerase accessory function. J. Virol. 69:1669-1677.
23. Kirchner, E. A., G. W. Bornkamm, and A. Polack. 1991. Transcriptional activity across the Epstein-Barr virus genome in Raji cells during latency and after induction of an abortive lytic cycle. J. Gen. Virol. 72:2391-2398.
24. Laux, G., U. K. Freese, R. Fischer, A. Polack, E. Kofler, and G. W. Bornkamm. 1988. TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation. Virology 162:503-507.
25. Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741-752.
26. Levitt, D., and M. King. 1987. Methanol fixation permits flow cytometric analysis of immunofluorescent stained intracellular antigens. J. Immunol. Methods 96:233-237.
27. Loken, M. R., and L. A. Herzenherg. 1975. Analysis of cell populations with a fluorescence-activated cell sorter. Ann. N. Y. Acad. Sci. 254:163-171.
28. Luka, J., B. Kallin, and G. Klein. 1979. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94:228-231.
29. Miller, G., M. Rabson, and L. Heston. 1984. Epstein-Barr virus with heterogeneous DNA disrupts latency. J. Virol. 50:174-182.
30. Nonoyama, M., and J. S. Pagano. 1972. Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nature New Biol. 238:169-171.
31. Nutter, L. M., S. P. Grill, J. S. Li, R. S. Tan, and Y. C. Cheng. 1987. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells. Cancer Res. 47:4407-4412.
32. Ooka, T., G. M. Lenoir, G. Decaussin, G. W. Bornkamm, and J. Daillie. 1986. Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells. J. Virol. 58:671-675.
33. Parker, B. D., A. Bankier, S. Satchwell, B. Barrell, and P. J. Farrell. 1990. Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 179:339-346.
34. Pearson, G. R., B. Vroman, B. chase, T. Sculley, M. Hummel, and E. Kieff. 1983. Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. J. Virol. 47:193-201.
35. Polack, A., H. Delius, U. Zimber, and G. W. Bornkamm. 1984. Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji. Virology 133:146-157.
36. Pritchett, R., M. Pendersen, and E. Kieff. 1976. Complexity of EBV homologous DNA in continuous lymphoblasloid cell lines. Virology 74:227-231.
37. Pulvertaft, R. J. V. 1965. A study of malignant tumours in Nigeria by short-term tissue culture. J. Clin. Pathol. 18:261-273.
38. Raab-Traub, N., T. Dambaugh, and E. Kieff. 1980. DNA of Epslein-Barr virus. VII. B95-8, the previous prototype, is an unusual deletion derivative. Cell 22:257-267.
39. Roubal, J., and K. Roubalová. 1985. Effect of n-butyrate on superinfection of Raji lymphoblasloid cell line by Epstein-Barr virus. Acta Virol. 29:162-165.
40. Sairenji, T., R. C. Spiro, and R. E. Humphreys. 1984. Differential effect of TPA and n-butyrate on induction of li and EBV antigens in the P3HR-1 lymphoblastoid cell line. Hematol. Oncol. 2:381-389.
41. Sokal, R. R., and F. J. Rohlf. 1987. Introduction to biostatistics. W. H. Freeman & Co., New York, N.Y.
42. Takada, K. 1984. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33:27-32.
43. Tan, R. S., J. S. Li, S. P. Grill, L. M. Nutter, and Y. C. Cheng. 1986 Demonstration of Epstein-Barr virus-specific DNA polymcrasc in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma. Cancer Res. 46:5024-5028.
44. Tovey, M. G., G. Lenoir, and J. Begon-Lours. 1978. Activation of latent Epstein-Barr virus by antibody to human IgM. Nature 276:270-272.
45. Tsurumi, T., T. Daikoku, and Y. Nishiyama. 1994. Further characterization of the interaction between the Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit with regard to the 3'-to-5' exonucleolytic activity and stability of initiation complex at primer terminus. J. Virol. 68: 3354-3363.
46. Wilson, G., and G. Miller. 1979. Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants. Virology 95:351-358.
47. Wong, K. M., and A. J. Levine. 1989. Characterization of proteins encoded by the Epstein-Barr virus transactivator gene BMLF1. Virology 168:101-111.
48. Zhang, C. X., G. Decaussin, J. Daillie, and T. Ooka. 1988. Altered expression of two Epstein-Barr virus early genes localized in Bam HI-A in nonproducer Raji cells. J. Virol. 62:1862-1869.
49. Zimber, U., H. K. Adldinger, G. M. Lenoir, M. Vuillaume, M. V. Knebel-Doeberitz, G. Laux, C. Desgranges, P. Wittmann, U. K. Freese, U. Schneider, and G. W. Bornkamm. 1986. Geographical prevalence of two types of Epstein-Barr virus. Virology 154:56-66.
50. zur Hausen, H., F. J. O'Neill, L. K. Freese, and E. Hecker. 1978. Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 272: 373-375.